Medication therapy management	Control	Vitality	-1	-1	Vitality <TAB> –4.9 ± 16.3 <TAB> 2.8 ± 12.9 <TAB> 0.08
Medication therapy management	Control	Medication appropriateness index improvement 	2115	2469	The targeted MTM intervention resulted in statistically significant CDR adjusted differences between groups with regard to improved MAI (change score of 3.6 (1.1) for the MTM group as compared with 1.0 (0.9) for the control group, p = 0.04) and ADS (change score of 1.0 (0.3) for the MTM group as compared with 0.2 (0.3) for the control group, p = 0.03).
Medication therapy management	Control	 Social functioning		-1	-1	Social functioning <TAB> –1.7 ± 29.2 <TAB> 0.5 ± 20.6 <TAB> 0.76
Medication therapy management	Control	 Physical functioning		-1	-1	<td> Physical functioning</td><td>3.6 ± 16.0</td><td>–5.2 ± 15.6</td><td>0.06</td>
Medication therapy management	Control	 Social functioning		-1	-1	<td> Social functioning</td><td>–1.7 ± 29.2</td><td>0.5 ± 20.6</td><td>0.76</td>
Medication therapy management	Control	Vitality	-1	-1	<td> Vitality</td><td>–4.9 ± 16.3</td><td>2.8 ± 12.9</td><td>0.08</td>
Medication therapy management	Control	Anticholinergic drug scale improvement 	2115	2469	The targeted MTM intervention resulted in statistically significant CDR adjusted differences between groups with regard to improved MAI (change score of 3.6 (1.1) for the MTM group as compared with 1.0 (0.9) for the control group, p = 0.04) and ADS (change score of 1.0 (0.3) for the MTM group as compared with 0.2 (0.3) for the control group, p = 0.03).
Medication therapy management	Control	 Physical functioning		-1	-1	Physical functioning <TAB> 3.6 ± 16.0 <TAB> –5.2 ± 15.6 <TAB> 0.06
